Fig. 10
In vivo T1-MRI images of BxPc-3 tumor-bearing mice after intravenous injection of the targeted (UPG-CD326) (a) and nontargeted (UPG) (b) micelles at designated time points (Red dotted circles show the site of tumor, values mean T1, unit: ms). c Comparison of the relative MRI intensities between targeted and nontargeted groups at the different time points (*p < 0.05, **p < 0.01)